UroGen (URGN) 2025 Earnings: What Investors Should Know
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
Discover what to know about cash back and taxes to manage your finances better. Stay informed and make wise decisions.
28,655 articlesAs UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
Rivian is rolling out its smaller R2 SUV, and deliveries have begun. As investors watch the headlines, the big questi...
A SpaceX IPO could reshape growth investing, creating upside for Rivian and other high-growth names. This guide break...
How do two AI infrastructure players compare when it comes to revenue scale? This article breaks down the factors, me...
In February, Figma exhibited a notable stock move as investor interest focused on cloud-based collaboration tools. Th...
When markets wobble, investors look for guidance. This piece breaks down Warren Buffett's wisdom on market correction...
Alphabet shifted gears, stepping away from a $346B AI bet to chase faster AI-driven wins. Here’s what that means for ...
A much-hyped self-directed Roth IRA move to buy rental real estate inside the retirement wrapper can backfire. Expert...
A real-world phishing incident taught me a hard lesson: protecting yourself from credit card theft starts with simple...
A stock that surged 49% in 2025 can still be tempting in 2026. This guide breaks down how to assess a semiconductor p...
In this artificial intelligence stocks march moment, savvy investors seek clarity on durable bets. This guide breaks ...
When a big fund buys in after a sharp drop, it sends a message about confidence and risk. This piece breaks down what...